140 related articles for article (PubMed ID: 36734312)
1. Metformin use and hospital attendance-related resources utilization among diabetic patients with prostate cancer on androgen deprivation therapy: A population-based cohort study.
Lee YHA; Hui JMH; Chung CT; Liu K; Dee EC; Ng K; Tse G; Chan JSK; Ng CF
Cancer Med; 2023 Apr; 12(8):9128-9132. PubMed ID: 36734312
[TBL] [Abstract][Full Text] [Related]
2. Metformin use and mortality in Asian, diabetic patients with prostate cancer on androgen deprivation therapy: A population-based study.
Lee YHA; Hui JMH; Chan JSK; Liu K; Dee EC; Ng K; Tang P; Tse G; Ng CF
Prostate; 2023 Jan; 83(1):119-127. PubMed ID: 36178848
[TBL] [Abstract][Full Text] [Related]
3. Androgen deprivation therapy for prostate cancer and the risk of thyroid diseases.
Liu JM; Chen YT; Wu CT; Hsu WL; Hsu RJ
Prostate; 2022 May; 82(7):809-815. PubMed ID: 35226371
[TBL] [Abstract][Full Text] [Related]
4. Risks of metabolic diseases and androgen deprivation therapy for prostate cancer in a Chinese population: a prospective multi-centre cohort study.
Wong C; Chu P; Teoh J; Chiu P; Yee CH; Chau L; Chan M; Wan H; Leung S; Ng CF
Int Urol Nephrol; 2022 May; 54(5):993-1000. PubMed ID: 35217907
[TBL] [Abstract][Full Text] [Related]
5. Metformin for Prevention of Anthropometric and Metabolic Complications of Androgen Deprivation Therapy in Prostate Cancer Patients Receiving Radical Radiotherapy: A Phase II Randomized Controlled Trial.
Usmani N; Ghosh S; Sanghera KP; Ong AD; Koul R; Dubey A; Ahmed S; Quon H; Yee D; Parliament M; Sivananthan G; Hunter W; Danielson B; Rowe L; McDonald M; Kim JO
Int J Radiat Oncol Biol Phys; 2023 Feb; 115(2):317-326. PubMed ID: 35907513
[TBL] [Abstract][Full Text] [Related]
6. Racial disparities in new-onset diabetes mellitus in prostate cancer patients on androgen deprivation therapy: a retrospective analysis of TriNetX data.
Gomaa S; Kelly WK; Mitchell E; Storozynsky E; Zeigler-Johnson C; Juon HS; Wen KY
World J Urol; 2023 Sep; 41(9):2351-2357. PubMed ID: 37555986
[TBL] [Abstract][Full Text] [Related]
7. A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapy.
Nobes JP; Langley SE; Klopper T; Russell-Jones D; Laing RW
BJU Int; 2012 May; 109(10):1495-502. PubMed ID: 21933330
[TBL] [Abstract][Full Text] [Related]
8. Risk of diabetes complications among those with diabetes receiving androgen deprivation therapy for localized prostate cancer.
Bradley MC; Zhou Y; Freedman AN; Yood MU; Quesenbery CP; Haque R; Van Den Eeden SK; Cassidy-Bushrow AE; Aaronson D; Potosky AL
Cancer Causes Control; 2018 Aug; 29(8):785-791. PubMed ID: 29959604
[TBL] [Abstract][Full Text] [Related]
9. Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer.
Crawley D; Garmo H; Rudman S; Stattin P; Häggström C; Zethelius B; Holmberg L; Adolfsson J; Van Hemelrijck M
Int J Cancer; 2016 Dec; 139(12):2698-2704. PubMed ID: 27557616
[TBL] [Abstract][Full Text] [Related]
10. Metformin addition to androgen deprivation therapy effect on cancer prostate patients with type 2 diabetes.
Aboelnaga EM; Aboelnaga MM; Elkalla HM
Diabetes Metab Syndr; 2021; 15(5):102251. PubMed ID: 34428740
[TBL] [Abstract][Full Text] [Related]
11. Risk of New-Onset Prostate Cancer for Metformin Versus Sulfonylurea Use in Type 2 Diabetes Mellitus: A Propensity Score-Matched Study.
Lee YHA; Zhou J; Hui JMH; Liu X; Lee TTL; Hui K; Chan JSK; Wai AKC; Wong WT; Liu T; Ng K; Lee S; Dee EC; Zhang Q; Tse G
J Natl Compr Canc Netw; 2022 Jun; 20(6):674-682.e15. PubMed ID: 35714677
[TBL] [Abstract][Full Text] [Related]
12. Retrospective cohort study of androgen deprivation therapy and the risk of diabetes in men with prostate cancer in Lithuania.
Drevinskaite M; Patasius A; Kincius M; Urbonas V; Smailyte G
BMJ Open; 2021 Jul; 11(7):e045797. PubMed ID: 34321292
[TBL] [Abstract][Full Text] [Related]
13. Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer.
Mahalingam D; Hanni S; Serritella AV; Fountzilas C; Michalek J; Hernandez B; Sarantopoulos J; Datta P; Romero O; Pillai SMA; Kuhn J; Pollak M; Thompson IM
Oncotarget; 2023 Jun; 14():622-636. PubMed ID: 37335291
[TBL] [Abstract][Full Text] [Related]
14. Statin reduces the risk of dementia in diabetic patients receiving androgen deprivation therapy for prostate cancer.
Liu JM; Chen TH; Chuang HC; Wu CT; Hsu RJ
Prostate Cancer Prostatic Dis; 2019 May; 22(2):276-283. PubMed ID: 30337635
[TBL] [Abstract][Full Text] [Related]
15. Risk of fracture in men with prostate cancer on androgen deprivation therapy: a population-based cohort study in New Zealand.
Wang A; Obertová Z; Brown C; Karunasinghe N; Bishop K; Ferguson L; Lawrenson R
BMC Cancer; 2015 Nov; 15():837. PubMed ID: 26525985
[TBL] [Abstract][Full Text] [Related]
16. Androgen-deprivation therapy and risk of death from cardio-vascular disease in prostate cancer patients: a nationwide lithuanian population-based cohort study.
Jonušas J; Drevinskaitė M; Patašius A; Kinčius M; Janulionis E; Smailytė G
Aging Male; 2022 Dec; 25(1):173-179. PubMed ID: 35882633
[No Abstract] [Full Text] [Related]
17. Large institutional variations in use of androgen deprivation therapy with definitive radiotherapy in a population-based cohort of men with intermediate- and high-risk prostate cancer.
Ong WL; Foroudi F; Evans S; Millar J
BJU Int; 2017 Nov; 120 Suppl 3():35-42. PubMed ID: 28749017
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer.
Shah NJ; Patel VG; Zhong X; Pina L; Hawley JE; Lin E; Gartrell BA; Febles VA; Wise DR; Qin Q; Mellgard G; Joshi H; Nauseef JT; Green DA; Vlachostergios PJ; Kwon DH; Huang F; Liaw B; Tagawa S; Kantoff P; Morris MJ; Oh WK
JNCI Cancer Spectr; 2022 May; 6(3):. PubMed ID: 35657341
[TBL] [Abstract][Full Text] [Related]
19. Prostate Cancer-specific Survival After Radical Prostatectomy Is Improved Among Metformin Users but Not Among Other Antidiabetic Drug Users.
Joentausta RM; Rannikko A; Murtola TJ
Eur Urol Open Sci; 2021 Dec; 34():86-93. PubMed ID: 34934970
[TBL] [Abstract][Full Text] [Related]
20. Association between serum uric acid and prostate cancer mortality in androgen deprivation therapy: A population-based cohort study.
Lee YHA; Chan JSK; Leung CH; Hui JMH; Dee EC; Ng K; Liu K; Liu T; Tse G; Ng CF
Cancer Med; 2023 Aug; 12(16):17056-17060. PubMed ID: 37455552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
